ArticleGenome biology2026
Sex-specific nonlinear DNA methylation aging trajectories reveal biomarkers of cancer risk and inflammation.
Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Embracing non-linearity in human ageing.Nature reviews. Genetics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAging is a multi-modal process, leaving distinct molecular signatures across the epigenome. DNA methylation is among the most robust biomarkers of biological aging, yet most studies assume linear age relationships and analyze mixed-sex cohorts, overlooking known sex differences. Such approaches risk obscuring critical nonlinear transitions and sex-specific trajectories.
resultsWe develop SNITCH, a computational framework to detect complex nonlinear methylation trajectories and disentangle shared from sex-divergent patterns. Applied to the array-derived whole-blood methylomes from 252 females and 246 males (ages 19-90 years), SNITCH reveals convergent and divergent epigenetic aging pathways independent of immune cell composition. Nonlinear trajectories are enriched for developmental transcription factor motifs, including NF1/CTF and REST, with known oncogenic roles. Importantly, a female-specific nonlinear cluster is prospectively associated with cancer onset and systemic inflammation in an independent cohort, nominating clinically relevant biomarkers. We replicate the analysis in an additional cohort and highlight consistent nonlinear trajectories.
conclusionsOur results uncover sex-specific, nonlinear aging programs that capture the dynamics of epigenetic change beyond linear models. These findings provide potential candidate biomarkers for early disease risk and advance understanding of how aging trajectories diverge between sexes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.